Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
News
All News
Press Releases
Conferences
Conference Coverage
Conference Listing
Media
All Videos
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Medical World News
Podcasts
Precision Medicine
Publications
All Publications
CBPP Spotlight Live
Evolving Paradigms
Targeted Therapies in Oncology
Resources
Education
Partners
Subscribe
eNewsletter
Search
Featured Clinical Focus
AML
Biomarker-Driven Lung Cancer
Breast Cancer
CAR T-Cell Therapy
Chronic Lymphocytic Leukemia
EGFR+ Lung Cancer
Follicular Lymphoma
GI Cancers
HCC
HER2-Positive Breast Cancer
Lung Cancer
Lymphomas
Mantle Cell Lymphoma
MPNs
Multiple Myeloma
Prostate Cancer
Renal Cell Carcinoma
Thyroid Cancers
Clinical Focus
See All >
Brain Cancer
Breast Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Cancers
Head & Neck Cancers
Hematology
Leukemias
Lung Cancer
Lymphomas
Melanoma
Sarcoma
Skin Cancers
Thyroid Cancers
Evolving Approaches for HCC in the Molecular Medicine Era | Precision Medicine
An in-depth discussion on the targeting of specific molecular pathways with newer, novel therapies to better manage patients with liver cancer.
home
EP 1: Optimizing Care for Patients With Hepatocellular Carcinoma
EP 2: Hepatocellular Carcinoma Risk Stratification and Therapy
EP 3: Testing for Targetable Mutations in Hepatocellular Carcinoma
EP 4: Targeting the VEGF Pathway in Hepatocellular Carcinoma
EP 5: HCC: VEGF TKI Data and Treatment Selection
EP 6: PD-1/PD-L1 Antibodies and VEGF Inhibitors in HCC
EP 7: Atezolizumab/Bevacizumab Data in Frontline HCC
EP 8: Atezolizumab/Bevacizumab for HCC: Toxicity Management
EP 9: Choosing Between VEGF TKIs for Frontline HCC Treatment
EP 10: HCC Treatment After Previous I/O Therapy
EP 11: Novel Combinations Under Study for HCC
EP 12: Exciting Targets Under Study in HCC